Smartphone-based Ophthalmoscopy
Comparison of Smartphone-based Ophthalmoscopy Versus Dilated Ophthalmic Examination for Diabetic and Nondiabetic Eye Disease
1 other identifier
interventional
120
1 country
1
Brief Summary
A subset of 120 diabetic patients underwent dilated examination and smartphone ophthalmoscopy. The smartphone was equipped with a compact add-on that filtered and delivered the smartphone's LED light coaxially to the camera, allowing a clear and convenient view of the retina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 24, 2014
CompletedFirst Posted
Study publicly available on registry
June 30, 2014
CompletedJune 30, 2014
June 1, 2014
5 months
June 24, 2014
June 26, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Diabetic retinopathy grading
The grading was performed according to the Early Treatment Diabetic Retinopathy Study (ETDRS) diabetic retinopathy classification. Grade 0: no diabetic retinopathy Grade 1: mild non-proliferative diabetic retinopathy Grade 2: average non-proliferative diabetic retinopathy Grade 3: severe non-proliferative diabetic retinopathy Grade 4: proliferative diabetic retinopathy
The same day as dilated ophthalmic examination
Study Arms (1)
Diabet patients
EXPERIMENTALSmartphone ophthalmoscopy followed by traditional slit-lamp dilated ophthalmoscopy
Interventions
Eligibility Criteria
You may qualify if:
- type 1 or 2 diabetes
- ability to provide written informed consent
You may not qualify if:
- significant optic media opacities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Università degli Studi di Brescialead
- Luisa Delcassicollaborator
- Nausica Ghilardicollaborator
Study Sites (1)
Spedali Civili di Brescia
Brescia, BS, 25123, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD Researcher
Study Record Dates
First Submitted
June 24, 2014
First Posted
June 30, 2014
Study Start
November 1, 2013
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
June 30, 2014
Record last verified: 2014-06